• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A phase II study of liposomal doxorubicin, vincristine and dexamethasone in multiple myeloma.

作者信息

Hönemann Dirk, Prince H Miles, Seymour John F, Wolf Max M, Westerman David, Januszewicz E Henry

出版信息

Leuk Lymphoma. 2005 Jun;46(6):945-7. doi: 10.1080/10428190500057684.

DOI:10.1080/10428190500057684
PMID:16019544
Abstract
摘要

相似文献

1
A phase II study of liposomal doxorubicin, vincristine and dexamethasone in multiple myeloma.
Leuk Lymphoma. 2005 Jun;46(6):945-7. doi: 10.1080/10428190500057684.
2
A Phase II trial of pegylated liposomal doxorubicin, vincristine, and reduced-dose dexamethasone combination therapy in newly diagnosed multiple myeloma patients.聚乙二醇化脂质体阿霉素、长春新碱和低剂量地塞米松联合治疗新诊断多发性骨髓瘤患者的II期试验。
Cancer. 2002 Nov 15;95(10):2160-8. doi: 10.1002/cncr.10946.
3
Bortezomib plus dexamethasone is superior to vincristine plus doxorubicin plus dexamethasone as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma: results of the IFM 2005-01 phase III trial.硼替佐米联合地塞米松优于长春新碱联合多柔比星联合地塞米松作为新诊断多发性骨髓瘤患者自体造血干细胞移植前的诱导治疗：IFM 2005-01 期 III 期试验结果。
J Clin Oncol. 2010 Oct 20;28(30):4621-9. doi: 10.1200/JCO.2009.27.9158. Epub 2010 Sep 7.
4
Clinical benefits and economic analysis of pegylated liposomal doxorubicin/vincristine/dexamethasone versus doxorubicin/vincristine/dexamethasone in patients with newly diagnosed multiple myeloma.聚乙二醇化脂质体阿霉素/长春新碱/地塞米松与阿霉素/长春新碱/地塞米松治疗新诊断多发性骨髓瘤患者的临床疗效及经济分析
Clin Lymphoma Myeloma. 2007 Apr;7 Suppl 4:S150-5. doi: 10.3816/clm.2007.s.016.
5
Pegylated liposomal doxorubicin, vincristine, and dexamethasone provide significant reduction in toxicity compared with doxorubicin, vincristine, and dexamethasone in patients with newly diagnosed multiple myeloma: a Phase III multicenter randomized trial.聚乙二醇化脂质体阿霉素、长春新碱和地塞米松与阿霉素、长春新碱和地塞米松相比，可显著降低新诊断的多发性骨髓瘤患者的毒性：一项III期多中心随机试验。
Cancer. 2006 Feb 15;106(4):848-58. doi: 10.1002/cncr.21662.
6
Is double autologous stem-cell transplantation appropriate for new multiple myeloma patients?
Nat Clin Pract Oncol. 2008 Feb;5(2):70-1. doi: 10.1038/ncponc1005. Epub 2007 Nov 6.
7
Hematology: Thalidomide maintenance in multiple myeloma.
Nat Rev Clin Oncol. 2009 Oct;6(10):565-6. doi: 10.1038/nrclinonc.2009.131.
8
Prospective randomized comparison of vincristine, doxorubicin and dexamethasone (VAD) administered as intravenous bolus injection and VAD with liposomal doxorubicin as first-line treatment in multiple myeloma.多柔比星脂质体联合长春新碱和地塞米松（VAD）静脉推注与普通多柔比星联合长春新碱和地塞米松（VAD）作为多发性骨髓瘤一线治疗的前瞻性随机对照研究
Ann Oncol. 2003 Jul;14(7):1039-44. doi: 10.1093/annonc/mdg287.
9
Post-transplant outcomes of induction therapy for myeloma: thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high-dose melphalan with autologous stem cell support.骨髓瘤诱导治疗的移植后结局：沙利度胺与地塞米松对比多柔比星、长春新碱及地塞米松用于高剂量美法仑联合自体干细胞支持治疗之前
Am J Hematol. 2007 Dec;82(12):1071-5. doi: 10.1002/ajh.21038.
10
Phase II clinical trial of arsenic trioxide with liposomal doxorubicin, vincristine, and dexamethasone in newly diagnosed multiple myeloma.三氧化二砷联合脂质体阿霉素、长春新碱和地塞米松用于新诊断多发性骨髓瘤的II期临床试验。
Leuk Res. 2008 Aug;32(8):1295-8. doi: 10.1016/j.leukres.2007.10.020. Epub 2007 Dec 21.